Teyi Pharmaceutical Group (002728.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
According to the Zhitong Finance APP, Teyi Pharmaceutical Group (002728.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved a revenue of 0.456 billion yuan, a year-on-year decrease of 38.87%. Net income attributable to shareholders of the listed company was 6.0098 million yuan, a year-on-year decrease of 96.81%. Net income after deducting non-recurring gains and losses attributable to shareholders of the listed company was 2.4083 million yuan, a year-on-year decrease of 98.70%.